Literature DB >> 22101682

Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).

Clare V Logan1, Barbara Lucke, Caroline Pottinger, Zakia A Abdelhamed, David A Parry, Katarzyna Szymanska, Christine P Diggle, Anne van Riesen, Joanne E Morgan, Grace Markham, Ian Ellis, Adnan Y Manzur, Alexander F Markham, Mike Shires, Tim Helliwell, Mariacristina Scoto, Christoph Hübner, David T Bonthron, Graham R Taylor, Eamonn Sheridan, Francesco Muntoni, Ian M Carr, Markus Schuelke, Colin A Johnson.   

Abstract

Infantile myopathies with diaphragmatic paralysis are genetically heterogeneous, and clinical symptoms do not assist in differentiating between them. We used phased haplotype analysis with subsequent targeted exome sequencing to identify MEGF10 mutations in a previously unidentified type of infantile myopathy with diaphragmatic weakness, areflexia, respiratory distress and dysphagia. MEGF10 is highly expressed in activated satellite cells and regulates their proliferation as well as their differentiation and fusion into multinucleated myofibers, which are greatly reduced in muscle from individuals with early onset myopathy, areflexia, respiratory distress and dysphagia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101682     DOI: 10.1038/ng.995

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  15 in total

1.  IBDfinder and SNPsetter: tools for pedigree-independent identification of autozygous regions in individuals with recessive inherited disease.

Authors:  Ian M Carr; Eamonn Sheridan; Bruce E Hayward; Alexander F Markham; David T Bonthron
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

2.  Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease.

Authors:  Ulf-Peter Guenther; Lusy Handoko; Raymonda Varon; Ulrich Stephani; Chang-Yong Tsao; Jerry R Mendell; Susanne Lützkendorf; Christoph Hübner; Katja von Au; Sibylle Jablonka; Gunnar Dittmar; Udo Heinemann; Anja Schuetz; Markus Schuelke
Journal:  J Mol Med (Berl)       Date:  2008-09-18       Impact factor: 4.599

3.  Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.

Authors:  K Grohmann; M Schuelke; A Diers; K Hoffmann; B Lucke; C Adams; E Bertini; H Leonhardt-Horti; F Muntoni; R Ouvrier; A Pfeufer; R Rossi; L Van Maldergem; J M Wilmshurst; T F Wienker; M Sendtner; S Rudnik-Schöneborn; K Zerres; C Hübner
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis.

Authors:  Ulf-Peter Guenther; Raymonda Varon; Maria Schlicke; Véronique Dutrannoy; Alexander Volk; Christoph Hübner; Katja von Au; Markus Schuelke
Journal:  Hum Mutat       Date:  2007-08       Impact factor: 4.878

5.  A congenital myopathy with diaphragmatic weakness not linked to the SMARD1 locus.

Authors:  L Hartley; M Kinali; R Knight; E Mercuri; C Hubner; E Bertini; A Y Manzur; C Jimenez-Mallebrera; C A Sewry; F Muntoni
Journal:  Neuromuscul Disord       Date:  2007-01-22       Impact factor: 4.296

6.  The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern.

Authors:  Emiko Suzuki; Manabu Nakayama
Journal:  Exp Cell Res       Date:  2007-04-19       Impact factor: 3.905

7.  Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.

Authors:  Terry P Maddatu; Sean M Garvey; David G Schroeder; Thomas G Hampton; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2004-04-06       Impact factor: 6.150

8.  Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor.

Authors:  Hsiao-Huei Wu; Elena Bellmunt; Jami L Scheib; Victor Venegas; Cornelia Burkert; Louis F Reichardt; Zheng Zhou; Isabel Fariñas; Bruce D Carter
Journal:  Nat Neurosci       Date:  2009-11-15       Impact factor: 24.884

9.  HomozygosityMapper--an interactive approach to homozygosity mapping.

Authors:  Dominik Seelow; Markus Schuelke; Friedhelm Hildebrandt; Peter Nürnberg
Journal:  Nucleic Acids Res       Date:  2009-05-21       Impact factor: 16.971

10.  Megf10 regulates the progression of the satellite cell myogenic program.

Authors:  Chet E Holterman; Fabien Le Grand; Shihuan Kuang; Patrick Seale; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2007-12-03       Impact factor: 10.539

View more
  35 in total

1.  Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.

Authors:  Madhurima Saha; Skylar A Rizzo; Manashwi Ramanathan; Rylie M Hightower; Katherine E Santostefano; Naohiro Terada; Richard S Finkel; Jonathan S Berg; Nizar Chahin; Christina A Pacak; Richard E Wagner; Matthew S Alexander; Isabelle Draper; Peter B Kang
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

2.  The impact of Megf10/Drpr gain-of-function on muscle development in Drosophila.

Authors:  Isabelle Draper; Madhurima Saha; Hannah Stonebreaker; Robert N Salomon; Bahar Matin; Peter B Kang
Journal:  FEBS Lett       Date:  2019-03-12       Impact factor: 4.124

3.  Characterization of the expression and cell-surface localization of transmembrane protein 132A.

Authors:  Kentaro Oh-hashi; Hisashi Koga; Takahiro Nagase; Yoko Hirata; Kazutoshi Kiuchi
Journal:  Mol Cell Biochem       Date:  2012-07-22       Impact factor: 3.396

4.  Silencing of drpr leads to muscle and brain degeneration in adult Drosophila.

Authors:  Isabelle Draper; Lane J Mahoney; Satomi Mitsuhashi; Christina A Pacak; Robert N Salomon; Peter B Kang
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

Review 5.  Exome sequencing greatly expedites the progressive research of Mendelian diseases.

Authors:  Xuejun Zhang
Journal:  Front Med       Date:  2014-01-03       Impact factor: 4.592

6.  Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions.

Authors:  Madhurima Saha; Satomi Mitsuhashi; Michael D Jones; Kelsey Manko; Hemakumar M Reddy; Christine C Bruels; Kyung-Ah Cho; Christina A Pacak; Isabelle Draper; Peter B Kang
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

7.  Cysteine mutations cause defective tyrosine phosphorylation in MEGF10 myopathy.

Authors:  Satomi Mitsuhashi; Hiroaki Mitsuhashi; Matthew S Alexander; Hiroyuki Sugimoto; Peter B Kang
Journal:  FEBS Lett       Date:  2013-08-15       Impact factor: 4.124

8.  Megf10 Is a Receptor for C1Q That Mediates Clearance of Apoptotic Cells by Astrocytes.

Authors:  Tal Iram; Zaida Ramirez-Ortiz; Michael H Byrne; Uwanda A Coleman; Nathan D Kingery; Terry K Means; Dan Frenkel; Joseph El Khoury
Journal:  J Neurosci       Date:  2016-05-11       Impact factor: 6.167

Review 9.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

10.  Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).

Authors:  Tyler Mark Pierson; Thomas Markello; John Accardi; Lynne Wolfe; David Adams; Murat Sincan; Noor M Tarazi; Karin Fuentes Fajardo; Praveen F Cherukuri; Ilda Bajraktari; Katy G Meilleur; Sandra Donkervoort; Mina Jain; Ying Hu; Tanya J Lehky; Pedro Cruz; James C Mullikin; Carsten Bonnemann; William A Gahl; Cornelius F Boerkoel; Cynthia J Tifft
Journal:  Neuromuscul Disord       Date:  2013-03-01       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.